Asad Haider

Asad Haider, Head of the U.S. Healthcare Business Unit at Goldman Sachs Research, dives into healthcare's recent struggles due to AI shifts and policy uncertainties. Amit Sinha, Head of Life Sciences Investing at Goldman Sachs Asset Management, discusses why private capital is crucial for biotech and highlights groundbreaking advancements in areas like genetics and immunology. Both guests uncover innovative pockets within the industry, from oral obesity treatments to oncology strategies, painting a hopeful picture amid challenges.